Hepatitis E virus: Blood transfusion implications;Virus de l'hépatite E, implications en transfusion sanguine

Transfusion Clinique et Biologique

Volumn 21, Issue 4-5, 2014, Pages 173-177

  Gallian, P ^a,b   Piquet, Y ^a   Assal, A ^a   Djoudi, R ^a   Chiaroni, J ^a   Izopet, J ^c,d,e   Tiberghien, P ^a,f  

^a ETABLISSEMENT FRANÇAIS DU SANG   (France)

^b Aix Marseille University IRD 190 Inserm 1207   (France)

^c University of Toulouse III   (France)

^d UNIVERSITÉ PAUL SABATIER   (France)

^e TOULOUSE UNIVERSITY HOSPITAL   (France)

^f UNIVERSITÉ DE FRANCHE COMTÉ   (France)

Author keywords

Blood transfusion; HEV; NAT; Prevalence

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; VIRUS RNA; DETERGENT; HEPATITIS ANTIBODY; IMMUNOGLOBULIN G; SOLVENT;

ARTICLE; BLOOD DONOR; BLOOD SAFETY; BLOOD TRANSFUSION; CHRONIC HEPATITIS; FRANCE; GENOTYPE; HEMATOLOGIC MALIGNANCY; HEPATITIS E; HEPATITIS E VIRUS; HEPATITIS E VIRUS GENOTYPE 3; HEPATITIS E VIRUS GENOTYPE 4; HUMAN; INFECTION PREVENTION; NONHUMAN; SEROPREVALENCE; VIRUS TRANSMISSION; ADVERSE EFFECTS; BLOOD; COMMUNICABLE DISEASES, EMERGING; DEVELOPING COUNTRY; DONOR SELECTION; DRUG EFFECTS; GENETICS; HEALTH; IMMUNOLOGY; ISOLATION AND PURIFICATION; NUCLEIC ACID AMPLIFICATION; PLASMA; RISK; STANDARDS; TRANSMISSION; VIREMIA; VIROLOGY; VIRUS INACTIVATION;

BLOOD DONORS; BLOOD SAFETY; BLOOD TRANSFUSION; COMMUNICABLE DISEASES, EMERGING; DETERGENTS; DEVELOPING COUNTRIES; DONOR SELECTION; FRANCE; GENOTYPE; GLOBAL HEALTH; HEPATITIS ANTIBODIES; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; IMMUNOGLOBULIN G; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PLASMA; RISK; RNA, VIRAL; SEROEPIDEMIOLOGIC STUDIES; SOLVENTS; VIREMIA; VIRUS INACTIVATION;

EID: 84924441737     PISSN: 12467820     EISSN: 19538022     Source Type: Journal    
DOI: 10.1016/j.tracli.2014.07.007     Document Type: Article

References (23)

1. Kamar N., Bendall R., Legrand-Abravanel F., Xia N.S., Ijaz S., Izopet J., et al. Hepatitis E. Lancet 2012, 379:2477-2488.
2. Colson P., Borentain P., Queyriaux B., Kaba M., Moal V., Gallian P., et al. Pig liver sausage as a source of hepatitis E virus transmission to humans. J Infect Dis 2010, 202:825-834.
3. Slot E., Hogema B.M., Riezebos-Brilman A., Kok T.M., Molier M., Zaaijer H.L. Silent hepatitis E virus infection in Dutch blood donors, 2011to 2012. Euro Surveill 2013, 18.
4. Ijaz S., Szypulska R., Tettmar K.I., Kitchen A., Tedder R.S. Detection of hepatitis E virus RNA in plasma mini-pools from blood donors in England. Vox Sang 2012, 102:272.
5. Baylis S.A., Koc O., Nick S., Blumel J. Widespread distribution of hepatitis E virus in plasma fractionation pools. Vox Sang 2012, 102:182-183.
6. Boxall E., Herborn A., Kochethu G., Pratt G., Adams D., Ijaz S., et al. Transfusion-transmitted hepatitis E in a "non-hyperendemic" country. Transfus Med 2006, 16:79-83.
7. Colson P., Coze C., Gallian P., Henry M., De Micco P., Tamalet C. Transfusion-associated hepatitis E, France. Emerg Infect Dis 2007, 13:648-649.
8. Haim-Boukobza S., Ferey M.P., Vetillard A.L., Jeblaoui A., Pelissier E., Pelletier G., et al. Transfusion-transmitted hepatitis E in a misleading context of auto-immunity and drug-induced toxicity. J Hepatol 2012, 57:1374-1378.
9. Matsubayashi K., Kang J.H., Sakata H., Takahashi K., Shindo M., Kato M., et al. A case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route. Transfusion 2008, 48:1368-1375.
10. Matsubayashi K., Nagaoka Y., Sakata H., Sato S., Fukai K., Kato T., et al. Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan. Transfusion 2004, 44:934-940.
11. Coilly A., Haïm-Boukobza S., Roche B., Antonini T.M., Pause A., Mokhtari C., et al. Post-transplantation hepatitis E: transfusion-transmitted hepatitis rising from the ashes. Transplantation 2013, 96.
12. Hauser L., Roque-Afonso A.M., Beylouné A., Simonet M., Deau Fischer B., et al. Hepatitis E transmission by transfusion of intercept blood system-treated plasma. Blood 2014, 123:796-797.
13. Féray C., Pawlotsky J.M., Roque-Afonso A.M., Samuel D., Dhumeaux D. Should we screen blood products for hepatitis E virus RNA?. Lancet 2014, 383:218.
14. Gallian P., Lhomme S., Piquet Y., Sauné K., Abravanel F., Assal A., et al. Prevalence of Silent HEV infections in blood donors, France. Emerg Infect Dis 2014, [accepté pour publication].
15. Cleland A., Smith L., Crossan C., Blatchford O., Dalton H.R., Scobie L., et al. Hepatitis E virus in Scottish blood donors. Vox Sang 2013, 105:283-289.
16. Baylis S.A., Gartner T., Nick S., Ovemyr J., Blumel J. Occurrence of hepatitis E virus RNA in plasma donations from Sweden, Germany and the United States. Vox Sang 2012, 103:89-90.
17. Corman V.M., Drexler J.F., Eckerle I., Roth W.K., Drosten C., Eis-Hubinger A.M. Zoonotic hepatitis E virus strains in German blood donors. Vox Sang 2013, 104:179-180.
18. Guo Q.S., Yan Q., Xiong J.H., Ge S.X., Shih J.W., Ng M.H., et al. Prevalence of hepatitis E virus in Chinese blood donors. J Clin Microbiol 2010, 48:317-318.
19. Vollmer T., Diekmann J., Johne R., Eberhardt M., Knabbe C., Dreier J. Novel approach for detection of hepatitis E virus infection in German blood donors. J Clin Microbiol 2012, 50:2708-2713.
20. Mansuy J.M., Bendall R., Legrand-Abravanel F., Saune K., Miedouge M., Ellis V., et al. Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis 2011, 17:2309-2312.
21. Beale M.A., Tettmar K., Szypulska R., Tedder R.S., Ijaz S. Is there evidence of recent hepatitis E virus infection in English and North Welsh blood donors?. Vox Sang 2011, 100:340-342.
22. Xu C., Wang R.Y., Schechterly C.A., Ge S., Shih J.W., Xia N.S., et al. An assessment of hepatitis E virus (HEV) in US blood donors and recipients: no detectable HEV RNA in 1939donors tested and no evidence for HEV transmission to 362prospectively followed recipients. Transfusion 2013, 53:2505-2511.
23. Hogema B.M., Molier M., Slot E., Zaaijer H.L. Past and present of hepatitis E in the Netherlands. Transfusion 2014.